Treatment of Osteopenic Menopause Women as a Public Health Problem with Nasal Calcitonin; an Original Study on Follow up Markers
<strong>Introduction:</strong> Various therapeutic options such as Calcitonin are suggested for patients with low bone density. However, the efficacy remains uncertain in all patients. C-telopeptide of type I collagen (CTx) is the authentic bone marker which is recently used to assess th...
Main Authors: | Bita Najafian, Majid Shohrati, Amin Saburi, Zahra Abbasi, Gholam-Hossein Alishiri, Noushin Bayat |
---|---|
Format: | Article |
Language: | English |
Published: |
International Travel Medicine Center of Iran
2014-09-01
|
Series: | International Journal of Travel Medicine and Global Health |
Subjects: | |
Online Access: | http://www.ijtmgh.com/article_33293_0faa4217d0c89f33b1bfd991adbf8016.pdf |
Similar Items
-
Effects of calcitonin nasal spray on serum bone resorptive marker CTX and other laboratory findings in osteopenic menopausal women: a clinical trial
by: Bayat N, et al.
Published: (2012-07-01) -
The Efficacy of Nasal Calcitonin on The Treatment of Osteoporosis in Male Patients with Ankylosing Spondylitis: A Preliminary Study - Original Investigation
by: Pınar Borman, et al.
Published: (2007-09-01) -
Two Years of Alendronate and Calcitonin Treatments for Osteoporosis in Postmenopausal Women - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01) -
The Comparison of Effects of Alendronate and Calcitonin Treatment in Men With Osteoporosis
by: Gülcan Gürer, et al.
Published: (2004-09-01) -
The Effect of Continous or Intermittent Calcitonin in the Treatment of Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-03-01)